Get started
Author

Chao Zhan

Observed name: Zhan, Chao
ORCID: 0000-0001-5732-8857
Observed ORCID: 0000-0001-5732-8857
OpenAlex ID: A5100710702
Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.
2015 · Shouping Xu, Shiyao Sui, et al. · PubMed · 146
MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1α
2014 · Haitao Xu, Liang Zhao, et al. · PLoS ONE · 104
PDF
CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma
2018 · Dongliang Li, Yongjian Zhang, et al. · Journal of Experimental & Clinical Cancer Research · 77
PDF
Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer
2015 · Shou-ping Xu, Jin-feng Zhang, et al. · Tumor Biology · 59
Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation
2015 · Huan Nie, Xia Liu, et al. · Scientific Reports · 57
PDF
Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2
2019 · Xin Lu, Xiaohan Zhang, et al. · Molecular Carcinogenesis · 52
NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44
2021 · Xiaoqing Zhang, Peng Dou, et al. · Oncogene · 36
Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest
2016 · Hongwei Zhao, Yubao Zhang, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 30
Dynamic Contrast-Enhanced Ultrasonography with Sonazoid for Diagnosis of Microvascular Invasion in Hepatocellular Carcinoma
2021 · Xintong Li, Xue Han, et al. · Ultrasound in Medicine & Biology · 26
PDF
Comprehensive characterization and evaluation of hepatocellular carcinoma by LC–MS based serum metabolomics
2015 · Xin Lu, Huan Nie, et al. · Metabolomics · 20
Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and Normal Samples
2020 · Xiaohan Zhang, Xiuyun Shi, et al. · Journal of Cancer · 19
PDF
Bioinformatic-based mechanism identification of E2F1-related ceRNA and E2F1 immunoassays in hepatocellular carcinoma
2022 · Wenlei Dong, Chao Zhan · Journal of Gastrointestinal Oncology · 12
PDF
Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma
2023 · Haoran Zhao, Haishi Liu, et al. · BMC Medical Genomics · 11
PDF
Integration of pre-trained protein language models with equivariant graph neural networks for peptide toxicity prediction
2025 · Shihu Jiao, Xiucai Ye, et al. · BMC Biology · 10
PDF
Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma
2023 · Chunxun Liu, Zhaowei Qu, et al. · BMC Bioinformatics · 6
PDF
Comparing neoadjuvant targeted therapy plus transarterial chemoembolization versus triple therapy including immunotherapy in hepatocellular carcinoma: a Chinese multicentre study
2025 · Hao Yu, Quan Yuan, et al. · Cancer Immunology Immunotherapy · 5
PDF
TXSelect: A multi-task learning model to identify secretory effectors
2025 · Jing Li, Qing Liu, et al. · PLoS Computational Biology · 2
PDF
DCMF-PPI: a protein-protein interaction predictor based on dynamic condition and multi-feature fusion
2025 · Siqi Chen, Anhong Zheng, et al. · BMC Bioinformatics · 2
PDF
Multi-omics integration of TPX2 in prognostic prediction in resectable hepatocellular carcinoma
2025 · Haoran Zhao, Weiwei Duan, et al. · Discover Oncology · 2
PDF
Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma
2024 · Zhiwei Li, Xiaona Fan, et al. · The Oncologist · 2
Optimal Transport in Single-Cell Multi-Omics Integration: Advances, Challenges, Limitations, and Future Directions
2026 · Jiacheng Wang, Quan Zou, et al. · Current Bioinformatics
Value of ZSCAN9 in the treatment and survival prediction of hepatocellular carcinoma: a bioinformatics study
2025 · Suwei Jing, Wenlei Dong, et al. · Translational Cancer Research
AttenRNA: multi-scale deep attentive model with RNA feature variability analysis
2025 · Jing Li, Quan Zou, et al. · Briefings in Bioinformatics
PDF
Nab-Paclitaxel Plus S-1 Followed by Gemcitabine-Oxaliplatin as First-Line Alternating Sequential Treatment of Pancreatic Ductal Adenocarcinoma (PDAC): A Single-Arm, Prospective Phase II Study
2023 · Li. Zhiwei, Qingwei Li, et al. · SSRN Electronic Journal
Comprehensive Analysis of Expression and Prognostic Value for JMJD5 and PKM2 in Stomach Adenocarcinoma
2021 · Ling Qi, Li-Sha Li, et al. · Research Square
PDF
Works count: 31
Citation count: 678
H-index: 12
I10-index: 14
Year
Topic
Type